Biotechnology Daily
more-
Beacon Biosignals lights the way to FDA nod for AI-powered sleep monitoring headset
Beacon Biosignals is living out a dream scenario: Mere weeks after acquiring EEG headset maker…
Mayo Clinic, GE HealthCare launch tech-driven theranostic imaging collaboration
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
FDA clears wearable ECG patches from Samsung spinout Wellysis, SmartCardia
Delayed TIL 2024: FDA resource constraints push back decision on Iovance cell therapy
Market Watch
more-
Farfetch Stock Hits All-Time Low Amid Richemont Episode, Delisting Reports
Shares of Farfetch sank to an all-time low after the luxury group Richemont said it…
Bio Business News
more
BioNTech secures $90M from CEPI to partner on mpox vaccine as it enters clinic
BioNTech is taking its mRNA mpox vaccine into the clinic,…
Nobel laureate Carolyn Bertozzi joins Acepodia as biotech aims to transform cancer cell therapy
Acepodia has snagged Nobel laureate Carolyn Bertozzi, Ph.D., to serve…
Blackstone’s $250M bet beats Xarelto in bleeding trial, making case for Anthos’ ex-Novartis asset
Blackstone Life Sciences’ $250 million bet on an ex-Novartis drug…
World News
more
Stocks close with a round of records, Dow clinches 35,000
U.S. stocks swept to another round of records Monday as…
Equifax stock surges toward biggest gain in 12 years after ‘impressive’ business update
Shares of Equifax Inc. EFX, +7.84% shot up 9.3% into…
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Beacon Biosignals lights the way to FDA nod for AI-powered sleep monitoring headset
Mayo Clinic, GE HealthCare launch tech-driven theranostic imaging collaboration
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
FDA clears wearable ECG patches from Samsung spinout Wellysis, SmartCardia
BioNTech secures $90M from CEPI to partner on mpox vaccine as it enters clinic
Nobel laureate Carolyn Bertozzi joins Acepodia as biotech aims to transform cancer cell therapy
Blackstone’s $250M bet beats Xarelto in bleeding trial, making case for Anthos’ ex-Novartis asset
RayzeBio overshoots expectations with $311M IPO while Neumora hits $250M target
Farfetch Stock Hits All-Time Low Amid Richemont Episode, Delisting Reports
Marpai Shares Drop After Nasdaq’s Delisting Notice